All Stories

  1. MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines

    Article • Molecular Medicine Reports, November 2018, Spandidos Publications

    Nevim Aygün

  2. Non-B DNA Structures as Candidate Drug Targets Against Structural Chromosomal Instability

    Article • Current Pharmacogenomics and Personalized Medicine, November 2018, Bentham Science Publishers

    Nevim Aygün

  3. Biological, genetic and clinical features of neuroblastoma

    Article • Current Pediatric Reviews, August 2018, Bentham Science Publishers

    Nevim Aygün

  4. Acquired Chromosomal Abnormalities and Their Potential Formation Mechanisms in Solid Tumours

    Article • August 2017, IntechOpen

    Nevim Aygün

  5. Correlations between long inverted repeat (LIR) features, deletion size and distance from breakpoint in human gross gene deletions

    Article • Scientific Reports, February 2015, Springer Science + Business Media

    Nevim Aygün

  6. Effect of Cytotoxic Agents and Retinoic Acid on Myc-N Protein Expression in Neuroblastoma

    Article • Applied Immunohistochemistry & Molecular Morphology, January 2010, Wolters Kluwer Health

    Nevim Aygün

  7. Association of MYCN Amplification and 1p Deletion in Neuroblastomas with High Tumor Vascularity

    Article • Applied Immunohistochemistry & Molecular Morphology, June 2007, Wolters Kluwer Health

    Nevim Aygün

  8. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma

    Article • Cancer Genetics and Cytogenetics, January 2007, Elsevier

    Nevim Aygün